Manufacturing Tanabe pens deal to sell plants to Towa in post-buyout pivot BioSpaceAfter being bought by Bain for $3.3 billion, Tanabe has reached a deal to sell its manufacturing unit and 17 products.Read full story pharminent July 8, 2026 (Last updated: July 9, 2026) BioSpace After being bought by Bain for $3.3 billion, Tanabe has reached a deal to sell its manufacturing unit and 17 products. Read full story Post navigation Previous: AstraZeneca, GSK intensify China ties with Sino Biopharm dealsNext: Sino Biopharm Strikes Drug Licensing Deal With AstraZeneca, Deepens Partnership With GSK Related Stories Manufacturing Sandoz plans ‘vast and vertically integrated’ supply chain to support 100-biosimilar vision pharminent September 9, 2026 Manufacturing US puts $125m into personalised RNA therapy production pharminent September 2, 2026 Manufacturing Multispecifics are transforming the CDMO development architecture pharminent August 28, 2026